WealthTrust Axiom’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-866
| Closed | -$224K | – | 264 |
|
|
2023
Q4 | $224K | Hold |
866
| – | – | 0.07% | 208 |
|
|
2023
Q3 | $223K | Hold |
866
| – | – | 0.08% | 198 |
|
|
2023
Q2 | $247K | Hold |
866
| – | – | 0.08% | 197 |
|
|
2023
Q1 | $241K | Hold |
866
| – | – | 0.08% | 201 |
|
|
2022
Q4 | $240K | Hold |
866
| – | – | 0.08% | 188 |
|
|
2022
Q3 | $231K | Buy |
+866
| New | +$184K | 0.09% | 191 |
|
|
2022
Q1 | – | Sell |
-866
| Closed | -$207K | – | 271 |
|
|
2021
Q4 | $207K | Hold |
866
| – | – | 0.07% | 224 |
|
|
2021
Q3 | $245K | Buy |
866
+6
| +0.7% | +$1.97K | 0.08% | 196 |
|
|
2021
Q2 | $297K | Hold |
860
| – | – | 0.1% | 179 |
|
|
2021
Q1 | $240K | Hold |
860
| – | – | 0.08% | 191 |
|
|
2020
Q4 | $210K | Hold |
860
| – | – | 0.08% | 199 |
|
|
2020
Q3 | $243K | Hold |
860
| – | – | 0.1% | 154 |
|
|
2020
Q2 | $230K | Hold |
860
| – | – | 0.1% | 160 |
|
|
2020
Q1 | $272K | Hold |
860
| – | – | 0.13% | 133 |
|
|
2019
Q4 | $255K | Hold |
860
| – | – | 0.09% | 173 |
|
|
2019
Q3 | $200K | Hold |
860
| – | – | 0.07% | 203 |
|
|
2019
Q2 | $201K | Hold |
860
| – | – | 0.07% | 201 |
|
|
2019
Q1 | $203K | Sell |
860
-60
| -7% | -$18.9K | 0.07% | 201 |
|
|
2018
Q4 | $276K | Hold |
920
| – | – | 0.11% | 149 |
|
|
2018
Q3 | $325K | Hold |
920
| – | – | 0.11% | 151 |
|
|
2018
Q2 | $267K | Hold |
920
| – | – | 0.09% | 175 |
|
|
2018
Q1 | $251K | Hold |
920
| – | – | 0.09% | 179 |
|
|
2017
Q4 | $293K | Hold |
920
| – | – | 0.11% | 163 |
|
|
2017
Q3 | $288K | Hold |
920
| – | – | 0.11% | 162 |
|
|
2017
Q2 | $249K | Hold |
920
| – | – | 0.09% | 183 |
|
|
2017
Q1 | $251K | Hold |
920
| – | – | 0.09% | 186 |
|
|
2016
Q4 | $260K | Hold |
920
| – | – | 0.09% | 169 |
|
|
2016
Q3 | $287K | Hold |
920
| – | – | 0.11% | 156 |
|
|
2016
Q2 | $222K | Hold |
920
| – | – | 0.09% | 181 |
|
|
2016
Q1 | $239K | Hold |
920
| – | – | 0.09% | 160 |
|
|
2015
Q4 | $281K | Hold |
920
| – | – | 0.11% | 147 |
|
|
2015
Q3 | $268K | Hold |
920
| – | – | 0.11% | 149 |
|
|
2015
Q2 | $371K | Hold |
920
| – | – | 0.14% | 123 |
|
|
2015
Q1 | $388K | Hold |
920
| – | – | 0.14% | 123 |
|
|
2014
Q4 | $312K | Hold |
920
| – | – | 0.11% | 146 |
|
|
2014
Q3 | $304K | Hold |
920
| – | – | 0.11% | 145 |
|
|
2014
Q2 | $290K | Hold |
920
| – | – | 0.1% | 151 |
|
|
2014
Q1 | $281K | Hold |
920
| – | – | 0.1% | 140 |
|
|
2013
Q4 | $257K | Hold |
920
| – | – | 0.1% | 141 |
|
|
2013
Q3 | $221K | Buy |
+920
| New | +$206K | 0.09% | 144 |
|
Other funds holding BIIB
WealthTrust Axiom's BIIB Position: Q1 2024 in Review
WealthTrust Axiom sold out of Biogen (BIIB) in Q1 2024, closing a stake of 866 shares — an estimated $224K sold.
WealthTrust Axiom first reported a position in BIIB in Q3 2013 and held it in 40 quarters. The position peaked at $388K in Q1 2015. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.
- WealthTrust Axiom reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
- WealthTrust Axiom sold 866 Biogen shares in Q1 2024, an estimated $224K.
- WealthTrust Axiom first reported a position in Biogen in Q3 2013 and held it in 40 quarters.
- WealthTrust Axiom's Biogen position peaked at $388K in Q1 2015.
- 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.
Based on WealthTrust Axiom's 13F filing for Q1 2024, filed 10 May 2024.